{"disease":{"id":"obstructive-hypertrophic-cardiomyopathy","name":"obstructive hypertrophic cardiomyopathy"},"drugs":{"marketed":[{"drug_id":"mavacamten","indication_name":"Obstructive hypertrophic cardiomyopathy (HCM)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Camzyos","generic_name":"MAVACAMTEN","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"cardiac myosin","drug_class":"Cardiac Myosin Inhibitor [EPC]","quality_score":65,"revenue":"600","mechanism":"Mavacamten selectively inhibits cardiac myosin, reducing force-producing cross-bridge formation and improving cardiac function in HCM."},{"drug_id":"myk-461","indication_name":"Obstructive hypertrophic cardiomyopathy (HCM)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Camzyos","generic_name":"MYK-461","company_name":"Myokardia Inc","drug_phase":"marketed","molecular_target":"Myosin-7","drug_class":"Cardiac Myosin Inhibitor [EPC]","quality_score":51,"revenue":null,"mechanism":"Camzyos works by inhibiting the Myosin-7 protein, which is involved in the thickening of heart muscle cells."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05100420","title":"Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Montreal Heart Institute","has_results":false},{"nct_id":"NCT05489705","title":"A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)","phase":"","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06598995","title":"Myocardial Bridging in Obstructive Hypertrophic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":968,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT06146660","title":"A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06609382","title":"Left Ventricular Mass Index Predicts Clinical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy","phase":"","overall_status":"COMPLETED","enrollment_count":490,"lead_sponsor_name":"Changrong Nie","has_results":false},{"nct_id":"NCT04603521","title":"Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)","phase":"","overall_status":"COMPLETED","enrollment_count":325,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT03723655","title":"A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT05186818","title":"Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT03470545","title":"Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"MyoKardia, Inc.","has_results":true},{"nct_id":"NCT07529938","title":"Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT06580717","title":"ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT07383025","title":"Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT05767346","title":"Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Cytokinetics","has_results":false},{"nct_id":"NCT07168655","title":"Mavacamten in Obstructive Hypertrophic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07107373","title":"A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06224621","title":"Percutaneous Endocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic Cardiomyopathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT06551129","title":"Real-world Patient Reported Outcomes Among Patients Treated With Camzyos","phase":"","overall_status":"RECRUITING","enrollment_count":118,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06338202","title":"Real-World Effectiveness of Mavacamten in Canada","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03767855","title":"A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Cytokinetics","has_results":false},{"nct_id":"NCT05648825","title":"Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Xiang Wei","has_results":false},{"nct_id":"NCT05569382","title":"Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Morten Steen Kvistholm Jensen","has_results":false},{"nct_id":"NCT05174416","title":"A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"LianBio LLC","has_results":true},{"nct_id":"NCT05879523","title":"A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Shandong Suncadia Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT04826185","title":"A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Imbria Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05726799","title":"Use of Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive Cardiomyopathy: Comparison With the Classical Approach","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Michele De Bonis","has_results":false},{"nct_id":"NCT03442764","title":"A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"MyoKardia, Inc.","has_results":true},{"nct_id":"NCT07004972","title":"A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07367724","title":"Ademetionine in Obstructive Hypertrophic Cardiomyopathy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT06856265","title":"Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT06116968","title":"An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Corxel Pharmaceuticals","has_results":false},{"nct_id":"NCT07023341","title":"A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04783766","title":"Safety, Tolerability and Pharmacokinetics Study of CK-3773274","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Corxel Pharmaceuticals","has_results":false},{"nct_id":"NCT06023186","title":"Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Michael Ayers","has_results":false},{"nct_id":"NCT06354556","title":"Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Shandong Suncadia Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06211595","title":"Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Hangzhou Valgen Medtech Co., Ltd","has_results":false},{"nct_id":"NCT06775886","title":"Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Montefiore Medical Center","has_results":false}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}